Synergy CHC Corp. SNYR revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Synergy CHC Corp. reported revenue across 3 business segments; the largest, Nutraceuticals, was $29.7M, 97.9% of the filed sum (-11.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Nutraceuticals$29.7M97.9%-11.0% yoy
- Beverages$631K2.1%-55.7% yoy
- Consumer Goods$18K0.1%+6.4% yoy
Members sum to the consolidated $30.4M for this period.
- Retail$22.2Mshare n/a-16.0% yoy
- Online$8.13Mshare n/a-2.7% yoy
- License Revenue$2.9Mshare n/ano prior
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$27.3M89.9%-11.4% yoy
- Canada$2.42M8.0%-38.4% yoy
- Mexico$624K2.1%+17042.9% yoy
- Other$20.7K0.1%-71.6% yoy
Members sum to the consolidated $30.4M for this period.
- Nutraceuticals$4.82M87.8%-27.3% yoy
- Beverages$668K12.2%+2056.7% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.